Cardiology Perspective

 
 
  • Jun 8, 2018 This Week in Cardiology   Better equations for CV risk prediction, a drug for bradycardia, illicit drugs and MI in the young, EHR woes, and vitamins for CV risk reduction are discussed in this week's podcast.
  • How Hubris Impairs the Care of the Elderly Some conditions in older adults warrant treatment; some do not. The wise physician knows the difference.
  • Physiological Analysis of ORBITA Trial Yields New Lessons   Speaking with Dr Rasha Al-Lamee, ORBITA's lead investigator, on the latest data to come out of the controversial trial.
  • Echo Case: Possibly an All-Time Record Case of…   One of the worst cases Dr Wharton has seen. Can you decipher from the M-modes alone as the echocardiographers of old had to?
  • Malpractice Case: When Payment Should Not Be Part of the Issue Discontinuing treatment of a patient because the patient is unable to pay can lead to a malpractice lawsuit. This case shows what physicians should do to avoid being sued for abandonment of care.
  • Jun 01, 2018 This Week in Cardiology   Surgical left atrial appendage occlusion, renal denervation, a substudy of ORBITA, FFR and hypertension guidelines are discussed in this week's podcast.
  • Does Screening Newborns for Congenital Heart Disease Save Lives? These data might help states get on board with universal pulse oximetry screening for congenital heart disease.
  • CABANA in Context: A Nuanced Understanding of AF Ablation   Ablation or medical therapy for atrial fibrillation? Drs Hylek, Piccini, and Ruff describe the finer points of the CABANA trial, presented at the 2018 Heart Rhythm Scientific Sessions.
  • The Ethics of Keeping Alfie Evans Alive Saurabh Jha reviews the ethical dilemma posed by the UK case of a 23-month-old in a vegetative state that pitted physicians against parents and even the Pope.
  • How Many Kids Really Have High Blood Pressure? The normative values for BP have been updated. A new analysis shows that, as a result, more children are classified as having elevated readings.
  • Does Drinking More Water Improve Kidney Function?   If increasing the water intake lowers vasopressin levels, does it follow that it also improves kidney function? Dr Szczech shares her views.
  • Drug Safety Warnings and Updates: January-March 2018 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the first quarter of 2018.
  • IV Diltiazem and Other Shortages at Crisis Level A confluence of factors, including a hurricane, have left hospitals with shortages of saline and IV drugs. But long-term solutions will require the intervention of legislators, concludes Melissa Walton-Shirley, MD.
  • HRS 2018What Is the Role of Ablation for AF in a Post-CABANA World?   Electrophysiologists John Mandrola and Dhiraj Gupta discuss the CABANA trial results and what they mean for catheter ablation of patients with atrial fibrillation.
  • ACP Glycemic Target Guidance: An Author Makes the Case   Dr Jay H. Shubrook interviews Dr Timothy J. Wilt on ACP's updated guidance statement on pharmacologic treatment of nonpregnant patients with type 2 diabetes mellitus.
  • Extreme Diets: Fads and Facts Radical diets have exploded in popularity since the 19th century. We dig into notable examples -- from Fletcherism to liquid diets to Beverly Hills -- reviewing their history, claims, and impact.
  • May 18, 2018 This Week in Cardiology   Device-related thrombosis with Watchman left atrial appendage closure, debulking atrial fibrillation after ablation, rivaroxaban for stroke prevention, alteplase, and Lp(a) are discussed this week.
  • HRS 2018Potential Major Problem With a Common Pacing Lead A poster presentation at HRS on lead failure with a popular St Jude Medical lead echoed a case familiar to John Mandrola, MD. He wasn't the only concerned EP calling for further investigation.
  • HRS 2018AF Ablation vs Drugs: Insights From CABANA Investigators John Mandrola interviews the investigators of the breakout trial from the Heart Rhythm Scientific Sessions which compared catheter ablation versus drugs in patients with atrial fibrillation.
  • Intravenous tPA for Stroke: Putting the Controversy to Rest   Dr Mark Alberts addresses recent controversial statements by some cardiology colleagues and other medical specialists regarding the safety and efficacy of IV tPA in treating acute ischemic stroke.